Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. College of Medicine /醫學院
  3. Institute of Medicine/醫學研究所
  4. Co-targeting CDK4/6 enhances anti-cancer activity and alleviates immune-related adverse events of anti-PD-1 antibody for breast cancer
 
  • Details
Options

Co-targeting CDK4/6 enhances anti-cancer activity and alleviates immune-related adverse events of anti-PD-1 antibody for breast cancer

Journal
Cell Reports Medicine
Journal Volume
6
Journal Issue
11
Start Page
102429
ISSN
2666-3791
Date Issued
2025-11
Author(s)
Shu-Wei Hu
Ming-Hsin Yeh
Yu-Hao He
Ya-Ling Wei
Fang-Ju Cheng
Yi-Lun Yeh
Thanh Kieu Huynh
Pei-Tong Liu
Dai-Wei Hu
Tzu-Hsuan Chang
Bo-Wei Wang
Bo-Rong Chen
Mei-Chun Lin
Der-Yen Lee
Yi-Hsien Hsieh  
Yuan-Man Hsu
Chih-Hsin Tang
Ping-Chih Ho
Mien-Chie Hung
Wei-Chien Huang
DOI
10.1016/j.xcrm.2025.102429
URI
https://scholars.csmu.edu.tw/handle/123456789/5394
Publisher
Elsevier BV
Type
journal-article
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback